Roderick MacKinnon, Director at Flex Pharma, Inc. (FLKS), bought 10,000 shares at $7.03 ($70K) on 2016-03-11, disclosed to the SEC on 2016-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.